CTI BioPharma Initiates Rolling Submission of U.S. NDA for Pacritinib for Treatment of Patients with Myelofibrosis
November 23, 2015 at 04:10 AM EST
CTI BioPharma Corp. (NASDAQ: CTIC) announced the initiation of its rolling new drug application (NDA) to the U.S. Food and Drug ...